Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy
about
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trialStaging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy.Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer.Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvementSentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for LymphedemaDo the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?Sentinel lymph nodes for breast carcinoma: an update on current practice.The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.p53 expression in breast cancer predicts tumors with low probability of non-sentinel nodes infiltration.Lymph Node Surgery - Stepwise Retirement for the Breast Surgeon?Two decades of axillary management in breast cancer.Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients?Rethinking the Local Therapy of Breast Cancer: Integration of Biology and Anatomy.Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.Trends and controversies in multidisciplinary care of the patient with breast cancer.The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.The impact of preoperative axillary ultrasonography in T1 breast tumours.Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.Sentinel node biopsy and improved patient care.Evaluation of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection for Breast Cancer Treatment Concepts - a Retrospective Study of 1,214 Breast Cancer Patients.Imaging and pathology features to predict axillary tumor load in breast cancer.Personalization of loco-regional care for primary breast cancer patients (part 1).Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.Overview of Breast Cancer Therapy
P2860
Q28085062-90003766-D830-4F01-82D6-29D21EBA0C68Q33684856-DEFD73E8-EE80-47C7-93B8-3C5162093737Q33802478-FADFF6D3-4895-4E72-8700-32FDC6D60D93Q34164742-5721FC5F-DDD3-40E6-AE4B-4E19EE1911E6Q35137186-D4AB9C34-4B8E-4188-BC9A-AAE715444744Q35184621-B433CB9E-C6CF-4A30-8DAE-44F2201F569CQ36089537-B943ED97-1BBD-4C13-BB68-C1212B2259F2Q36168193-D6C0B1FA-CF25-40F3-A9B8-6E0964833F0EQ36385250-33D0AC6E-9AE2-48CC-ADEF-CAC0A9C79587Q36396057-A783710B-B96E-4E04-8665-EF01B4EDF3CEQ36510469-F54DAADF-4035-426E-AC02-12A45BB878EAQ37265272-9D663066-5D61-4778-96C2-2976550E3433Q38295108-ECE5127B-3D0F-4E40-9B11-C860D8C32383Q38346114-2A79E670-C482-4BEF-ADBD-F049E40CCB5AQ38813226-81B78D0F-312A-42BC-8D81-9BD7D5C20F7AQ38928989-3A0534C1-3CD7-4862-8971-07D460037A91Q38961720-53D4395D-2E3B-4469-B4C8-7A30A7A9098FQ38980661-09A15C09-2972-436A-AC91-E3CDFD917F2AQ39029485-41088681-A342-476D-93F5-44477DCAC40BQ39119467-7947590B-C96B-4712-8697-A5253F20D63AQ40100099-1601593C-4A42-4EEE-B05E-AF40A87CEBD3Q40145590-CCAA3BC6-774E-4499-B68B-6217D614A935Q40684691-56BC7210-6D4B-48D5-B36F-A87A7750FDFBQ40750506-F2DA82DB-85A7-4A4F-8AA8-1D9C0449EC22Q40758847-DD52E69A-E88C-44F6-BC10-C3EC78CEE9B5Q46646028-5D46F255-84EB-4354-B89E-A7F7200C2BC7Q47320998-647D318B-6C28-443F-913A-84D518447509Q47805471-2CC0A00E-5129-4C36-B77B-85AEE113A16EQ48489316-33D1DBB0-5FDA-4E13-9A68-A85090B4A082Q49846863-436418C1-EB9B-48DD-8D5C-DD09C8C4B426Q55070760-B132B768-EB11-41C3-93B7-029B6F2F3BDCQ57110718-BE619937-97A9-40E2-A9B6-E1F47582DC5C
P2860
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Axillary dissection can be avo ...... oing breast-conserving therapy
@ast
Axillary dissection can be avo ...... oing breast-conserving therapy
@en
type
label
Axillary dissection can be avo ...... oing breast-conserving therapy
@ast
Axillary dissection can be avo ...... oing breast-conserving therapy
@en
prefLabel
Axillary dissection can be avo ...... oing breast-conserving therapy
@ast
Axillary dissection can be avo ...... oing breast-conserving therapy
@en
P2093
P2860
P50
P1476
Axillary dissection can be avo ...... oing breast-conserving therapy
@en
P2093
Deborah Capko
George Plitas
Hiram S Cody
Lisa M Sclafani
Lynn T Dengel
Manuela Junqueira
Mary L Gemignani
Sujata Patil
Tari A King
Virgilio S Sacchini
P2860
P2888
P356
10.1245/S10434-013-3200-6
P577
2013-08-22T00:00:00Z
P6179
1051572364